The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
Open accessAbstract
The exact connection between Alzheimer’s disease (AD) and type 2 diabetes is still in debate. However, poorly controlled blood sugar may increase the risk of developing Alzheimer’s. This relationship is so strong that some have called Alzheimer’s “diabetes of the brain” or “type 3 diabetes (T3D)”. Given more recent studies continue to indicate evidence linking T3D with AD, this review aims to demonstrate the relationship between T3D and AD based on the fact that both the processing of amyloid-β (Aβ) precursor protein toxicity and the clearance of Aβ are attributed to impaired insulin signaling, and that insulin resistance mediates the dysregulation of bioenergetics and progress to AD. Furthermore, insulin-related therapeutic strategies are suggested to succeed in the development of therapies for AD by slowing down their progressive nature or even halting their future complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · cited 1×
“Recently, many studies indicated that the incidence of AD is higher in T2D patients and obese individuals, implying common mechanisms driving these disorders [10,52,53].”
BackgroundFarris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Hubbard, S. R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5572 · Cited by 953
Bomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J.-C., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57256 · Cited by 832
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
McClean, P. L., Parthsarathy, V., Faivre, E., & Hölscher, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-11.2011 · Cited by 698
LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β
Peineau, S., Taghibiglou, C., Bradley, C., Wong, T. P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.029 · Cited by 695
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657
Baker, L. D., Cross, D. J., Minoshima, S., Belongia, D., Watson, G. S., & Craft, S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.225 · Cited by 639
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H., & Häring, H.-U. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 622
Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D. A., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 621
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Identification of insulin in rat brain.
Havrankova, J., Schmechel, D., Roth, J., & Brownstein, M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5737 · Cited by 605
Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536 · cited 2×
“Reduced levels of IRS-1 associated to the membrane of hippocampal extracts [65] and a decreased activation of IRS-1 and PI3K in the hippocampus and cortex were observed in ten-month-old mice [66].”
BackgroundBrain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis
Taguchi, A., Wartschow, L. M., & White, M. F. (2007) · Science · doi:10.1126/science.1142179 · Cited by 523
Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Cherrier, M. M., Schellenberg, G. D., Frey II, W. H., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13309 · Cited by 521
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
Herrup, K., & Yang, Y. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2124 · Cited by 507
Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 492
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
M. de la Monte, S. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 448
Insulin resistance as the core defect in type 2 diabetes mellitus
Goldstein, B. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02553-5 · Cited by 432
Chiu, S.-L., Chen, C.-M., & Cline, H. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.014 · Cited by 425
Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny-Germano, L., Batista, A. F., Sathler, L. B., Brito-Moreira, J., Amaral, O. B., Silva, C. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.002 · Cited by 420
Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
Gabbouj, S., Ryhänen, S., Marttinen, M., Wittrahm, R., Takalo, M., Kemppainen, S., Martiskainen, H., Tanila, H., Haapasalo, A., Hiltunen, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00629 · Cited by 401
Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.035 · Cited by 394
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
McClean, P. L., & Hölscher, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.005 · Cited by 361
Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2015) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Ovais, M., Ullah, I., Ahmed, J., & Shahid, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00155 · Cited by 320
Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review
de la Monte, S. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.008 · Cited by 313
Benedict, C., Kern, W., Schultes, B., Born, J., & Hallschmid, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2606 · Cited by 296 · cited 1×
“Insulin Only women presented improved working memory after treatment Healthy men and woman intranasally administrated [99]”
BackgroundAberrant insulin signaling in Alzheimer's disease: current knowledge
Bedse, G., Di Domenico, F., Serviddio, G., & Cassano, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00204 · Cited by 292
Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Martens, Y. A., Linares, C., Knight, J. A., Painter, M. M., Sullivan, P. M., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.003 · Cited by 289 · cited 2×
“After blocking the receptor, the sticky APOE4 protein begins to clump and becomes toxic [87].”
BackgroundBosco, D., Fava, A., Plastino, M., Montalcini, T., & Pujia, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01318.x · Cited by 283
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 262
Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M., Purganan, K., Wait, C., Petrova, A., Latendresse, S., Watson, G. S., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00087-2 · Cited by 255
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
Kroner, Z. (2009) · PubMed · Cited by 246
Batista, A. F., Forny‐Germano, L., Clarke, J. R., Lyra e Silva, N. M., Brito‐Moreira, J., Boehnke, S. E., Winterborn, A., Coe, B. C., Lablans, A., Vital, J. F., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5056 · Cited by 246
Escribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., Ricobaraza, A., Pérez-Mediavilla, A., Del Río, J., & Frechilla, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.32 · Cited by 235
Brain Insulin: Regulation, Mechanisms of Action and Functions
Gerozissis, K. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1022598900246 · Cited by 234
Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
Giau, V., Wu, S., Jamerlan, A., An, S., Kim, S., & Hulme, J. (2018) · Nutrients · doi:10.3390/nu10111765 · Cited by 232
Insulin Resistance in Alzheimer's Disease
Ferreira, L. S. S., Fernandes, C. S., Vieira, M. N. N., & De Felice, F. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00830 · Cited by 228
Lee, C.-C., Huang, C.-C., & Hsu, K.-S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.003 · Cited by 227
Freude, S., Hettich, M. M., Schumann, C., Stöhr, O., Koch, L., Köhler, C., Udelhoven, M., Leeser, U., Müller, M., Kubota, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132043 · Cited by 218
Clarke, J. R., Lyra e Silva, N. M., Figueiredo, C. P., Frozza, R. L., Ledo, J. H., Beckman, D., Katashima, C. K., Razolli, D., Carvalho, B. M., Frazão, R., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404183 · Cited by 214 · cited 2×
“Remarkably, the central infusion of AβOs lead to periphe l i sulin resistance, which was further observed in the APP/PS1 and in the 3xTgAD mouse models of AD [70].”
BackgroundPomytkin, I., Costa‐Nunes, J. P., Kasatkin, V., Veniaminova, E., Demchenko, A., Lyundup, A., Lesch, K., Ponomarev, E. D., & Strekalova, T. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12866 · Cited by 208
A biochemical and functional characterization of diet‐induced brain insulin resistance
Mielke, J. G., Taghibiglou, C., Liu, L., Zhang, Y., Jia, Z., Adeli, K., & Wang, Y. T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03155.x · Cited by 205
The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update
Hoyer, S. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200028 · Cited by 205
Apoptosis in pancreatic β-islet cells in Type 2 diabetes
Tomita, T. (2016) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2016.919 · Cited by 197
Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 195
Apelt, J., Mehlhorn, G., & Schliebs, R. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5<693::aid-jnr11>3.0.co;2-x · Cited by 178
Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood
Lee, S.-H., Zabolotny, J. M., Huang, H., Lee, H., & Kim, Y.-B. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.011 · Cited by 176
Insulin Is Released from Rat Brain Neuronal Cells in Culture
Clarke, D. W., Mudd, L., Boyd, F. T., Fields, M., & Raizada, M. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00686.x · Cited by 173
Role of apolipoprotein E in neurodegenerative diseases
Van Giau, V., Bagyinszky, E., An, S. S., & Kim, S. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84266 · Cited by 171
Self-citationLong-Smith, C. M., Manning, S., McClean, P. L., Coakley, M. F., O’Halloran, D., Hölscher, C., & O’Neill, C. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8199-5 · Cited by 168
The Insulin Receptor: Both a Prototypical and Atypical Receptor Tyrosine KinasePreprint
Hubbard, S. R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008946 · Cited by 168
Zheng, W., Kar, S., & Quirion, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002417200 · Cited by 167
Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression
Hancock, M. L., Meyer, R. C., Mistry, M., Khetani, R. S., Wagschal, A., Shin, T., Ho Sui, S. J., Näär, A. M., & Flanagan, J. G. (2019) · Cell · doi:10.1016/j.cell.2019.02.030 · Cited by 158
Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
Canhada, S., Castro, K., Perry, I. S., & Luft, V. C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1321813 · Cited by 156
Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
Killick, R., Scales, G., Leroy, K., Čaušević, M., Hooper, C., Irvine, E. E., Choudhury, A. I., Drinkwater, L., Kerr, F., Al‐Qassab, H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.032 · Cited by 151
The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
Broom, G. M., Shaw, I. C., & Rucklidge, J. J. (2018) · Nutrition · doi:10.1016/j.nut.2018.10.003 · Cited by 151
Periventricular hypothalamic cells in the rat brain contain insulin mRNA
Young, W. S. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90035-1 · Cited by 148
MedlineRanker: flexible ranking of biomedical literature
Fontaine, J.-F., Barbosa-Silva, A., Schaefer, M., Huska, M. R., Muro, E. M., & Andrade-Navarro, M. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp353 · Cited by 147
Changes in Blood Glucose and Insulin Secretion in Patients with Senile Dementia of Alzheimer Type
Bucht, G., Adolfsson, R., Lithner, F., & Winblad, B. G. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb03756.x · Cited by 147
Diabetes: What Challenges Lie Ahead for Vietnam?
Ngoc, N. B., Lin, Z. L., & Ahmed, W. (2020) · Annals of Global Health · doi:10.5334/aogh.2526 · Cited by 147
Obesity, Abdominal Obesity and Alzheimer Disease
Razay, G., Vreugdenhil, A., & Wilcock, G. K. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000094586 · Cited by 137
Weinstein, G., Davis‐Plourde, K. L., Conner, S. C., Himali, J. J., Beiser, A., Lee, A., Rawlings, A. M., Sedaghat, S., Ding, J., Moshier, E. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212293 · Cited by 123
Metabolic Alterations Associated to Brain Dysfunction in Diabetes
Duarte, J. M. N. (2014) · Aging and Disease · doi:10.14336/ad.2014.1104 · Cited by 119
Ruiz, H. H., Chi, T., Shin, A. C., Lindtner, C., Hsieh, W., Ehrlich, M. E., Gandy, S., & Buettner, C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.008 · Cited by 118
Role of Insulin Resistance in the Alzheimer's Disease Progression
Nguyen, T. T., Ta, Q. T. H., Nguyen, T. T. D., Le, T. T. H., & Giau, V. V. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03031-0 · Cited by 107
Self-citationMittal, K., Mani, R. J., & Katare, D. P. (2016) · Scientific Reports · doi:10.1038/srep25589 · Cited by 104
Cerebrovascular complications of diabetes: focus on cognitive dysfunction
Hardigan, T., Ward, R., & Ergul, A. (2016) · Clinical Science · doi:10.1042/cs20160397 · Cited by 104
Caberlotto, L., Nguyen, T.-P., Lauria, M., Priami, C., Rimondini, R., Maioli, S., Cedazo-Mínguez, Á., Sita, G., Morroni, F., Corsi, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39828-5 · Cited by 103
Self-citationCentral insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease
Velázquez, R., Tran, A., Ishimwe, E., Denner, L. A., Dave, N., Oddo, S., & Dineley, K. T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.003 · Cited by 91
Mitochondrial therapeutic interventions in Alzheimer’s disease
Giau, V. V., An, S. S. A., & Hulme, J. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.033 · Cited by 88
Frederiksen, K. S., Gjerum, L., Waldemar, G., & Hasselbalch, S. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170567 · Cited by 86
de Matos, A. M., Macedo, M. P., & Rauter, A. P. (2017) · Medicinal Research Reviews · doi:10.1002/med.21440 · Cited by 75
Cao, Y., Hölscher, C., Hu, M.-M., Wang, T., Zhao, F., Bai, Y., Zhang, J., Wu, M., & Qi, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.03.024 · Cited by 71
Rorbach-Dolata, A., & Piwowar, A. (2019) · BioMed Research International · doi:10.1155/2019/1435276 · Cited by 66
Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 63
Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt)
Kim, S.-J., & Han, Y. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0163-6 · Cited by 62
Insulin‐ and glucagonlike peptides in the brain
Dorn, A., Bernstein, H., Rinne, A., ZIEGLER, M., Hahn, H.-J., & ANSORGE, S. (1983) · The Anatomical Record · doi:10.1002/ar.1092070108 · Cited by 62
Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor
Xie, L., Martins, R. N., Racchi, M., Craft, S., & Helmerhorst, E. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4504 · Cited by 61
Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Taguchi, A., Tanokashira, D., & Fukuokaya, W. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253535 · Cited by 59
Mechanisms linking brain insulin resistance to Alzheimer's disease
Matioli, M. N. P. D. S., & Nitríni, R. (2015) · Dementia & Neuropsychologia · doi:10.1590/1980-57642015dn92000003 · Cited by 57
Cheng, L., Liu, W., Li, X., Zhang, Z., Qi, H., Liu, S., Yan, N., Xing, Y., Hölscher, C., & Wang, Z. (2020) · Brain and Behavior · doi:10.1002/brb3.1505 · Cited by 56
Nisr, R. B., & Affourtit, C. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.10.012 · Cited by 55
A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease
Ajith, T. A. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884713666180807145648 · Cited by 52
Current advances in transdermal delivery of drugs for Alzheimer's disease
Nguyen, T. T., Giau, V. V., & Vo, T. K. (2017) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.208143 · Cited by 51
Self-citationRaison d’être of insulin resistance: the adjustable threshold hypothesis
Wang, G. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0892 · Cited by 47
Panagaki, T., Gengler, S., & Hölscher, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180584 · Cited by 44
Gubellini, P., Picconi, B., Filippo, M. D., & Calabresi, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.001 · Cited by 40
Potential Antidiabetic Activity of Extracts and Isolated Compound from Adenosma bracteosum (Bonati)
Nguyen, N. H., Pham, Q. T., Luong, T. N. H., Le, H.-K., & Giau, V. V. (2020) · Biomolecules · doi:10.3390/biom10020201 · Cited by 38
Delikkaya, B., Moriel, N., Tong, M., Gallucci, G. M., & de la Monte, S. M. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.03.004 · Cited by 34
DA-JC1 improves learning and memory by antagonizing Aβ31–35-induced circadian rhythm disorder
Wang, L., Zhang, R., Hou, X., Wang, C., Guo, S., Ning, N., Sun, C., Yuan, Y., Li, L., Hölscher, C., et al. (2019) · Molecular Brain · doi:10.1186/s13041-019-0432-9 · Cited by 25
APOE ε4, the door to insulin‐resistant dyslipidemia and brain fog? A case study
Stoykovich, S., & Gibas, K. J. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.01.009 · Cited by 19
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Neuroinflammation in Alzheimer’s Disease
Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330
“AD has been referred to as “type 3 diabetes” [290,291].”
BackgroundNeuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304
Lima, J. E. B. F., Moreira, N. C. S., & Sakamoto-Hojo, E. T. (2022) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2021.503437 · Cited by 203
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Du, H., Meng, X., Yao, Y., & Xu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1033479 · Cited by 125
Metadata
- Authors
- Nguyen, T. T., Ta, Q. T. H., Nguyen, T. K. O., Nguyen, T. T. D., & Van Giau, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-30
- Volume
- 21
- Issue
- 9
- Pages
- 3165
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3022620811
- Cited by
- 393
- References
- 104
- FWCI
- 19.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.